A group of U.S. senators are digging into the direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer this ...

The Texas-based biotech sponsored a recent episode of “The Balancing Act,” a morning talk show that airs on Lifetime. Per an ...

There’s no denying it: the radiopharmaceuticals boom is here to stay. | Telix on Tuesday unveiled the spin-off of Rhine ...

Activist investor Starboard Value is baring its teeth at Pfizer management, more openly going after CEO Albert Bourla’s job.

With Johnson & Johnson sweetening the pot and mustering up the support of 83% of those who claim that the company’s talc ...

MacroGenics’ first commercial product, breast cancer drug Margenza, is heading off to TerSera Therapeutics through a $40 ...

With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one.

The upcoming winter months bring with them the annual cold and flu season—as well as “cuffing season” for singles everywhere.

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...

AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

Leo Pharma is launching a new U.S. healthcare awareness campaign aimed at doctors to boost their understanding of a specific ...

After calling for a major discount for Pfizer’s popular transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis, a U.S.